Evidence map›Paper›PMID 25265460›Full record

ArticleBone marrow transplantation2015

Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT.

V Bachanova, Q Cao, C Ustun, A T K Kendi, J Froelich, A Lazaryan, L J Burns

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2015
    Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

V BachanovaBone and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA.ORCID 000000029325432X
Q CaoStatistical Center, University of Minnesota, Minneapolis, MN, USA.
C UstunBone and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA.
A T K KendiStatistical Center, University of Minnesota, Minneapolis, MN, USA.
J FroelichDepartment of Radiology, University of Minnesota, Minneapolis, MN, USA.
A LazaryanBone and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA.
L J BurnsBone and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA.

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
NCATS NIH HHS UL1 TR000114NCATS NIH HHS UL1TR000114NCI NIH HHS P30 CA077598NCI NIH HHS P30 CA77598
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, Non-HodgkinPositron-Emission TomographyStem Cell TransplantationAdolescentAdultAgedAllograftsDisease-Free SurvivalFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedRadiographyRadiopharmaceuticalsSurvival RateFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID25265460
PMCPMC4753777

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.